OKYO Pharma (OKYO) is scheduled to report FY earnings on July 17, 2026. Analysts estimate EPS of $-0.13 and quarterly revenue of N/A.
In the most recent quarter (FY), OKYO Pharma reported EPS of $-0.20, missing estimates of $-0.17 by 0.18%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
OKYO Pharma has missed EPS estimates in 2 consecutive quarters.
Over the last 2 quarters, OKYO Pharma has averaged an EPS surprise of 0.59% and a revenue surprise of 0.00%.
Analyze the earnings history of OKYO Pharma using advanced sorting and filters.
The chart below shows OKYO Pharma's reported EPS compared to analyst estimates over recent quarters.
The chart below shows OKYO Pharma's reported revenue compared to analyst estimates over recent quarters.
OKYO Pharma (OKYO) is scheduled to report earnings on July 17, 2026. The last reported earnings were for reported on July 18, 2025 for FY.
The Actual EPS was $-0.20, which missed the estimate of $-0.17.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| FY | 2025-07-18 | $-0.20 | $-0.17 | -17.6 % |
| H1 | 2025-01-29 | $-0.08 | $-0.04 | -100.0 % |